A position paper challenges current ECG representation learning benchmarking practices, arguing that evaluation methods are too narrow and miss clinically meaningful objectives. The authors demonstrate that random encoder baselines surprisingly match state-of-the-art pre-training on many tasks, suggesting the field's conclusions about model performance are unreliable without proper evaluation frameworks.
The medical AI field faces a critical credibility problem in electrocardiogram (ECG) analysis research. Current benchmarking relies heavily on three public datasets dominated by arrhythmia detection and waveform morphology, creating a distorted view of model capabilities that ignores broader clinical applications like structural heart disease diagnosis and patient-level forecasting. This narrow evaluation landscape has allowed flawed conclusions about which representation learning approaches actually work best to persist in the literature.
The most striking finding—that randomly initialized encoders with linear probes match sophisticated pre-training methods across multiple tasks—exposes fundamental methodological failures in how the field validates progress. This suggests either that existing pre-training approaches provide minimal value over random initialization, or that evaluation practices are systematically biased. The research community has optimized models for specific benchmark metrics without ensuring these improvements translate to clinically relevant outcomes, a problem endemic to machine learning development when evaluation doesn't align with real-world deployment needs.
For AI developers and healthcare institutions, this work signals that published ECG model performance claims require skepticism until validated against diverse clinical endpoints. Organizations considering ECG AI tools should demand evaluation across structural disease detection and patient forecasting tasks, not just arrhythmia classification. The paper establishes best practices for multi-label, imbalanced medical datasets that the field should adopt broadly. Looking ahead, the community must expand benchmark diversity, implement rigorous baselines, and tie evaluation metrics directly to clinical outcomes that matter for patient care.
- →Current ECG benchmarking focuses narrowly on arrhythmia detection, missing broader clinical applications like structural heart disease and patient forecasting.
- →Random encoder baselines surprisingly match state-of-the-art pre-training on many tasks, indicating fundamental flaws in current evaluation methodology.
- →Best practices for multi-label, imbalanced evaluation settings alter conclusions about which representations actually perform best.
- →The field optimized for specific benchmarks without ensuring improvements translate to clinically meaningful outcomes.
- →Healthcare organizations should demand diverse clinical evaluation beyond standard benchmarks before deploying ECG AI models.